Clinical Trial Update: Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients

View source ↗

Summary

A clinical trial sponsored by Assiut University is evaluating serum Gasdermin D as a potential biomarker of disease activity in patients with vitiligo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Snippet

Sponsor: Assiut University | Conditions: Serum Gasdermin D in Vitiligo | Status: UNKNOWN